Armando Giuliano, MD

Surgical Oncology

Office: 310-423-9970Available 24/7: 1-800-CEDARS-1
  • SPECIALTY
  • CLINICAL AREAS
  • PROVIDER INFO
  • EDUCATION
  • AFFILIATIONS
  • RESEARCH & PUBLICATIONS
  • ACHIEVEMENTS

Office location

3104239970
8670 Wilshire Blvd. Second Floor
Beverly Hills
CA
90211

Specialty

  • Surgical Oncology

    Clinical Areas

    • Abnormal Mammograms
    • Breast Biopsy
    • Breast Cancers
    • Breast Disorders
    • Mastectomy
    • Parathyroid Disorders
    more

    Provider Info

    GENDER

    Male

    LANGUAGES

    English

    EXPERIENCE

    45 years

    Education

    • University of Chicago
      Medical School - Completed 1973
    • University of California, San Francisco School of Medicine
      Internship - Completed 1974
    • University of California, San Francisco School of Medicine
      Residency - Completed 1976
    • UCLA Medical Center
      Fellowship - Completed 1978
    • University of California, San Francisco School of Medicine
      Residency - Completed 1980

    Research

    Armando Giuliano, MD, has been a clinician-researcher for over 30 years. The main focus of his clinical research continues to be management of early breast cancer and quality of life of breast cancer patients. He served for five years as chairman of the Breast Organ Site Committee of the American College of Surgeons Oncology Group and was study chair for the sentinel node Z0010 and Z0011 studies which led to significant changes to the standard of care for patients with early breast cancer. He was previously a principal investigator for the NSABP and contributed to the lumpectomy study and to Alliance studies. He was a pioneer in sentinel node biopsy. This procedure has enabled early-stage breast cancer patients to avoid having more extensive surgery and reduces the incidence of complications such as lymphedema and shoulder problems. Giuliano also participates in translational research, merging what is learned in the clinic with knowledge gained in the laboratory. Under his direction, the scientists in the Breast Research Laboratory are actively studying triple negative breast cancer, BRCA-positive breast cancer, chemoresistance, and early metastases. Giuliano participates in the NCI's National Clinical Trials Network and is an active member of The Alliance for Clinical Trials in Oncology.

    PUBLICATIONS

    • Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow M. Axillary dissection vs. no axillary dissection in women with invasive breast cancer and sentinel node metastasis – a randomized clinical trial. JAMA. 2011;305(6):569-575.
    • Giuliano AE, Hawes D, Ballman KV, Whitworth PW, Blumencranz PW, Reintgen DS, Morrow M, Leitch AM, Hunt KK, McCall LM, et al. Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. JAMA. 2011;306(4):385-393.
    • Lyman GH, Temin S, Edge SB, Newman LA, Turner RR, Weaver Dl, Benson AB 3rd, Bosserman LD, Burstein JH, Cody H 3rd, Hayman J, Perkins CL, Podoloff DA, Giuliano AE. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2014;32(13):1365-1383.
    • Gangi A, Chung A, Mirocha J, Liou DZ, Leong T, Giuliano AE. Breast-conserving therapy for triple-negative breast cancer. JAMA Surg. 2014;149(3):252-258.
    more

    Achievements

    Board Certifications

    • Board Certified in Surgery

    Awards & Activities

    • Vice President, Society of Surgical Oncology - 2016-present
    • American College of Surgeons Board of Governors - 2014-17
    • Keynote Address: Lymphadenectomy for Breast Cancer: Past, Present, and Future. American Society of Breast Surgeons 15th Annual Meeting - 2014
    • James Ewing Lecture: The Rise and Fall of Lymphadenectomy for Breast Cancer. Society of Surgical Oncology 66th Annual Cancer Symposium - 2013